Pfizer announced that an experimental RSV vaccine for pregnant women protects newborns against severe illness for at least six months after birth
Pfizer announced on Tuesday that an experimental RSV vaccine for pregnant women protects newborns against severe illness for at least six months after birth.
RSV is a common respiratory virus that causes mild, cold-like symptoms. Even though most children and adults infected with RSV generally recover without significant long-term effects, Chang explained that the virus can be serious and even life-threatening for infants, younger kids and older adults. Severe infections can lead to bronchiolitis, an inflammation in the lung, as well as pneumonia.
Even though this vaccine has the potential to be a “game changer,” according to Chang, he noted that there are several factors that need to be taken into account, including that a significant burden of illness occurs in children older than 1 year of age. Furthermore, he said that RSV mortality is greatest among infants who are premature or who have. These patients, he added, may not benefit from this type of vaccination.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pfizer says study shows vaccinating pregnant women protects newborns from RSVThe preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close.
Weiterlesen »
Pfizer says study shows vaccinating pregnant women protects newborns from RSVThe preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close.
Weiterlesen »
Pfizer says study shows vaccinating pregnant women protects newborns from RSVThe preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close.
Weiterlesen »
Pfizer says study shows vaccinating pregnant women protects newborns from RSVThe preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close.
Weiterlesen »
Pfizer Says It Will Seek FDA Approval For A Maternal RSV Vaccine This YearInitial trail results of the maternal vaccine showed promising results for Pfizer. The pharmaceutical company will seek FDA approval this week.
Weiterlesen »
RSV Vaccine Given During Pregnancy Protects Newborns: PfizerNew trial data from drugmaker Pfizer shows promising effectiveness of a vaccine given to mothers during pregnancy that later protects infants in their first months from the most devastating effects of respiratory syncytial virus, or RSV.
Weiterlesen »